01898cam a2200409 i 4500 2012018433 20240305165658.0 m o d cr un ---uuuua 120503t20122012ilu ob 001 0 eng d 2012018433 9781614384786 40481 UtOrBLW eng rda UtOrBLW pcc n-us--- KF3133.B56 A86 2012 346.7304/86 23 ANDA litigation : strategies and tactics for pharmaceutical patent litigators / Kenneth L. Dorsney, editor-in-chief. Abbreviated New Drug Application litigation Chicago : American Bar Association, Section of Intellectual Property Law, [2012] ©2012 1 online resource (xxiii, 809 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references and index. Statutory and regulatory scheme -- Drug approval process - an overview -- Notice and pre-filing considerations -- Litigation timeline -- Initiating litigation -- Responding to the complaint -- Discovery -- Experts -- Claim construction -- Summary judgment -- Remedies -- Settlement -- Antitrust -- Pretrial preparation -- Trial -- Post-trial -- Appeals to the court of appeals for the federal circuit -- Pharmaceutical regulation and litigation in foreign countries -- Managing an ANDA litigation. Biotechnology United States Patents. Drugs United States Patents. Patent suits United States. Pharmacy Law and legislation United States. Abbreviated New Drug Application. Dorsney, Kenneth L. https://app.vlex.com/#/sources/40481 RAA 0 0 0 0 VLEX 331172 BD-UIN BD-UIN 2024-03-05 0 40481 2024-03-05 2024-03-05 RAA 173265 173265